Par Drugs and Chemicals share news, announcements and annual reports
NSE: PARPharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹120.70.
30 Oct: open ₹114.80, high ₹114.80, low ₹114.67
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹141 Cr2,825th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 10.86
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 13,907
Par Drugs and Chemicals share news and announcements
364 announcements, routine notices left out, newest first. Page 7 of 8.
Mar 2021
9 Mar · Corporate action
9 Mar · Board meeting
3 Mar · Analysts
Feb 2021
4 Feb · Board meeting
Jan 2021
29 Jan · Board meeting
Oct 2020
29 Oct · Results
29 Oct · Board meeting
Sep 2020
28 Sep · Board meeting
23 Sep · Board meeting
Aug 2020
17 Aug · Updates
17 Aug · Meeting
5 Aug · Board meeting
Jul 2020
29 Jul · Board meeting
21 Jul · Meeting
Jun 2020
15 Jun · Dividend
15 Jun · Corporate action
15 Jun · Board meeting
15 Jun · Meeting
11 Jun · Board meeting
1 Jun · Results
1 Jun · Board meeting
May 2020
18 May · Disclosure
Apr 2020
Mar 2020
Feb 2020
15 Feb · Updates
Jan 2020
24 Jan · Board meeting
16 Jan · Board meeting
Nov 2019
11 Nov · Board meeting
11 Nov · Corporate action
11 Nov · Board meeting